← Open Payments lookup

LOUIS BELZIE: Open Payments

NPI 1861438681 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$23,278 in 67 payments from 14 companies in 2025. Trend: 2023 $23,253 · 2024 $45,957 · 2025 $23,278

Speaker / faculty: $12,025Consulting: $7,935Food & beverage: $2,984Travel & lodging: $334
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.14$13,348
Janssen Pharmaceuticals, Inc15$8,130
Alkermes, Inc.9$421
Neurocrine BioSciences, Inc.7$374
Otsuka America Pharmaceutical, Inc.11$225
Luye Pharma (USA) Ltd.1$130
Phathom Pharmaceuticals, Inc.1$125
Teva Pharmaceuticals USA, Inc.1$122
Gilead Sciences, Inc.1$119
Takeda Pharmaceuticals U.S.A., Inc.1$119

Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, SPRAVATO, VOQUEZNA.

Industry payments across NY — which companies pay providers there.